The DOI matches its Crossref record; 146 of the 146 references it cites were found in a registry or an index.
Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis : Genes, Mutations, and Causalities
Open accessAbstract
Isoniazid (INH) is the cornerstone of tuberculosis (TB) chemotherapy, used for both treatment and prophylaxis of TB. The antimycobacterial activity of INH was discovered in 1952, and almost as soon as its activity was published, the first INH-resistant Mycobacterium tuberculosis strains were reported. INH and its structural analog and second-line anti-TB drug ethionamide (ETH) are pro-drugs. INH is activated by the catalase-peroxidase KatG, while ETH is activated by the monooxygenase EthA. The resulting active species reacts with NAD + to form an INH-NAD or ETH-NAD adduct, which inhibits the enoyl ACP reductase InhA, leading to mycolic acid biosynthesis inhibition and mycobacterial cell death. The major mechanism of INH resistance is mutation in katG, encoding the activator of INH. One specific KatG variant, S315T, is found in 94% of INH-resistant clinical isolates. The second mechanism of INH resistance is a mutation in the promoter region of inhA (c-15t), which results in inhA overexpression and leads to titration of the drug. Mutations in the inhA open reading frame and promoter region are also the major mechanism of resistance to ETH, found more often in ETH-resistant clinical isolates than mutations in the activator of ETH. Other mechanisms of resistance to INH and ETH include expression changes of the drugs’ activators, redox alteration, drug inactivation, and efflux pump activation. In this article, we describe each known mechanism of resistance to INH and ETH and its importance in M. tuberculosis clinical isolates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., et al. (1998) · Nature · doi:10.1038/31159 · Cited by 7,847
inhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosis
Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K. S., Wilson, T., Collins, D., de Lisle, G., & Jacobs, W. R. (1994) · Science · doi:10.1126/science.8284673 · Cited by 1,389 · cited 2×
“tuberculosis: the enoyl-ACP reductase InhA (56).”
BackgroundSelf-citationThe catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis
Zhang, Y., Heym, B., Allen, B., Young, D., & Cole, S. (1992) · Nature · doi:10.1038/358591a0 · Cited by 1,299
Snapper, S. B., Melton, R. E., Mustafa, S., Kieser, T., & Jr, W. R. J. (1990) · Molecular Microbiology · doi:10.1111/j.1365-2958.1990.tb02040.x · Cited by 1,237
Molecular genetic basis of antimicrobial agent resistance inMycobacterium tuberculosis: 1998 update
Ramaswamy, S., & Musser, J. M. (1998) · Tubercle and Lung Disease · doi:10.1054/tuld.1998.0002 · Cited by 1,089
Modification of the NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosis
Rozwarski, D. A., Grant, G. A., Barton, D. H. R., Jacobs, W. R., & Sacchettini, J. C. (1998) · Science · doi:10.1126/science.279.5347.98 · Cited by 682
McMurry, L., Petrucci, R. E., & Levy, S. B. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.3974 · Cited by 604
Wilson, M., DeRisi, J., Kristensen, H.-H., Imboden, P., Rane, S., Brown, P. O., & Schoolnik, G. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12833 · Cited by 547
Compensatory ahp C Gene Expression in Isoniazid-Resistant Mycobacterium tuberculosis
Sherman, D. R., Mdluli, K., Hickey, M. J., Arain, T. M., Morris, S. L., Barry, C. E., & Stover, C. K. (1996) · Science · doi:10.1126/science.272.5268.1641 · Cited by 436
Crystal Structure and Function of the Isoniazid Target of Mycobacterium tuberculosis
Dessen, A., Quémard, A., Blanchard, J. S., Jacobs, W. R., & Sacchettini, J. C. (1995) · Science · doi:10.1126/science.7886450 · Cited by 430
Inhibition of a Mycobacterium tuberculosis β-Ketoacyl ACP Synthase by Isoniazid
Mdluli, K., Slayden, R. A., Zhu, Y., Ramaswamy, S., Pan, X., Mead, D., Crane, D. D., Musser, J. M., & Barry, C. E. (1998) · Science · doi:10.1126/science.280.5369.1607 · Cited by 398
Hazbón, M. H., Brimacombe, M., Bobadilla del Valle, M., Cavatore, M., Guerrero, M. I., Varma-Basil, M., Billman-Jacobe, H., Lavender, C., Fyfe, J., García-García, L., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00112-06 · Cited by 374
Enzymic Characterization of the Target for Isoniazid in Mycobacterium tuberculosis
Quemard, A., Sacchettini, J. C., Dessen, A., Vilcheze, C., Bittman, R., Jacobs, W. R., & Blanchard, J. S. (1995) · Biochemistry · doi:10.1021/bi00026a004 · Cited by 373
Contribution of the Mycobacterium tuberculosis MmpL Protein Family to Virulence and Drug Resistance
Domenech, P., Reed, M. B., & Barry, C. E. (2005) · Infection and Immunity · doi:10.1128/iai.73.6.3492-3501.2005 · Cited by 361
Biosynthesis and Functions of Mycothiol, the Unique Protective Thiol of Actinobacteria
Newton, G. L., Buchmeier, N., & Fahey, R. C. (2008) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00008-08 · Cited by 353
Hillemann, D., Rüsch-Gerdes, S., & Richter, E. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00521-07 · Cited by 345
Ng, V. H., Cox, J. S., Sousa, A. O., MacMicking, J. D., & McKinney, J. D. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04078.x · Cited by 342
Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis
DeBarber, A. E., Mdluli, K., Bosman, M., Bekker, L.-G., & Barry, C. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9677 · Cited by 338
Ramaswamy, S. V., Reich, R., Dou, S.-J., Jasperse, L., Pan, X., Wanger, A., Quitugua, T., & Graviss, E. A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1241-1250.2003 · Cited by 336
Heym, B., Alzari, P. M., Honore, N., & Cole, S. T. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02238.x · Cited by 330
Rawat, R., Whitty, A., & Tonge, P. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235848100 · Cited by 330
Lysogeny and transformation in mycobacteria: stable expression of foreign genes.
Snapper, S. B., Lugosi, L., Jekkel, A., Melton, R. E., Kieser, T., Bloom, B. R., & Jacobs, W. R. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.18.6987 · Cited by 326
Self-citationTransfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid
Vilchèze, C., Wang, F., Arai, M., Hazbón, M. H., Colangeli, R., Kremer, L., Weisbrod, T. R., Alland, D., Sacchettini, J. C., & Jacobs, W. R. (2006) · Nature Medicine · doi:10.1038/nm1466 · Cited by 319
Self-citationMusser, J. M., Kapur, V., Williams, D. L., Kreiswirth, B. N., van Soolingen, D., & van Embden, J. D. A. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.1.196 · Cited by 313
Activation of the Pro-drug Ethionamide Is Regulated in Mycobacteria
Baulard, A. R., Betts, J. C., Engohang-Ndong, J., Quan, S., McAdam, R. A., Brennan, P. J., Locht, C., & Besra, G. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003744200 · Cited by 311
Mechanism of thioamide drug action against tuberculosis and leprosy
Wang, F., Langley, R., Gulten, G., Dover, L. G., Besra, G. S., Jacobs, W. R., & Sacchettini, J. C. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062100 · Cited by 303
PARA-AMINOSALICYLIC ACID IN THE TREATMENT OF TUBERCULOSIS
Lehmann, J. (1946) · The Lancet · doi:10.1016/s0140-6736(46)91185-3 · Cited by 295
Takayama, K., Wang, L., & David, H. L. (1972) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.2.1.29 · Cited by 292
ethA , inhA , and katG Loci of Ethionamide-Resistant Clinical Mycobacterium tuberculosis Isolates
Morlock, G. P., Metchock, B., Sikes, D., Crawford, J. T., & Cooksey, R. C. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3799-3805.2003 · Cited by 288
Altered NADH/NAD + Ratio Mediates Coresistance to Isoniazid and Ethionamide in Mycobacteria
Vilchèze, C., Weisbrod, T. R., Chen, B., Kremer, L., Hazbón, M. H., Wang, F., Alland, D., Sacchettini, J. C., & Jacobs, W. R. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.708-720.2005 · Cited by 284
Self-citationVilchèze, C., Morbidoni, H. R., Weisbrod, T. R., Iwamoto, H., Kuo, M., Sacchettini, J. C., & Jacobs, W. R. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.14.4059-4067.2000 · Cited by 283
Johnsson, K., & Schultz, P. G. (1994) · Journal of the American Chemical Society · doi:10.1021/ja00095a063 · Cited by 278
Pym, A. S., Saint-Joanis, B., & Cole, S. T. (2002) · Infection and Immunity · doi:10.1128/iai.70.9.4955-4960.2002 · Cited by 278
Streptomycin Resistance in Pulmonary Tuberculosis
Crofton, J., & Mitchison, D. A. (1948) · BMJ · doi:10.1136/bmj.2.4588.1009 · Cited by 261
Inhibition by Isoniazid of Synthesis of Mycolic Acids in Mycobacterium tuberculosis
Winder, F. G., & Collins, P. B. (1970) · Journal of General Microbiology · doi:10.1099/00221287-63-1-41 · Cited by 252
Schatz, A., & Waksman, S. A. (1944) · Experimental Biology and Medicine · doi:10.3181/00379727-57-14769 · Cited by 251
Isoniazid-resistance and catalase activity of tubercle bacilli; a preliminary report.
Middlebrook, G. (1954) · PubMed · doi:10.1164/art.1954.69.3.471 · Cited by 239
Efflux Pump-Mediated Intrinsic Drug Resistance in Mycobacterium smegmatis
Li, X.-Z., Zhang, L., & Nikaido, H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2415-2423.2004 · Cited by 239
Marrakchi, H., Lanéelle, G., & Quémard, A. (2000) · Microbiology · doi:10.1099/00221287-146-2-289 · Cited by 238
The Antituberculosis Drug Ethionamide Is Activated by a Flavoprotein Monooxygenase
Vannelli, T. A., Dykman, A., & Ortiz de Montellano, P. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110751200 · Cited by 232
Impact of Bacterial Genetics on the Transmission of Isoniazid-Resistant Mycobacterium tuberculosis
Gagneux, S., Burgos, M. V., DeRiemer, K., Enciso, A., Muñoz, S., Hopewell, P. C., Small, P. M., & Pym, A. S. (2006) · PLoS Pathogens · doi:10.1371/journal.ppat.0020061 · Cited by 230
Some Observations on the Pathogenicity of Isoniazid-Resistant Variants of Tubercle Bacilli
Middlebrook, G., & Cohn, M. L. (1953) · Science · doi:10.1126/science.118.3063.297 · Cited by 217
Action Mechanism of Antitubercular Isoniazid
Lei, B., Wei, C.-J., & Tu, S.-C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2520 · Cited by 208
Aínsa, J. A., Blokpoel, M. C. J., Otal, I., Young, D. B., De Smet, K. A. L., & Martín, C. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.22.5836-5843.1998 · Cited by 189
Colangeli, R., Helb, D., Sridharan, S., Sun, J., Varma‐Basil, M., Hazbón, M. H., Harbacheuski, R., Megjugorac, N. J., Jacobs, W. R., Holzenburg, A., et al. (2005) · Molecular Microbiology · doi:10.1111/j.1365-2958.2005.04510.x · Cited by 188
Towards a new tuberculosis drug: pyridomycin – nature's isoniazid
Hartkoorn, R. C., Sala, C., Neres, J., Pojer, F., Magnet, S., Mukherjee, R., Uplekar, S., Boy‐Röttger, S., Altmann, K., & Cole, S. T. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201689 · Cited by 188
Takayama, K., Schnoes, H. K., Armstrong, E. L., & Boyle, R. W. (1975) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)36719-5 · Cited by 185
Zhang, Y., Garbe, T., & Young, D. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01596.x · Cited by 179
Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis
Vilchèze, C., Av‐Gay, Y., Attarian, R., Liu, Z., Hazbón, M. H., Colangeli, R., Chen, B., Liu, W., Alland, D., Sacchettini, J. C., et al. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06365.x · Cited by 168
Self-citationEthA, a Common Activator of Thiocarbamide-Containing Drugs Acting on Different Mycobacterial Targets
Dover, L. G., Alahari, A., Gratraud, P., Gomes, J. M., Bhowruth, V., Reynolds, R. C., Besra, G. S., & Kremer, L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01063-06 · Cited by 168
Gupta, A. K., Katoch, V. M., Chauhan, D. S., Sharma, R., Singh, M., Venkatesan, K., & Sharma, V. D. (2009) · Microbial Drug Resistance · doi:10.1089/mdr.2009.0054 · Cited by 168
Novel Mutations in ndh in Isoniazid-Resistant Mycobacterium tuberculosis Isolates
Lee, A. S. G., Teo, A. S. M., & Wong, S.-Y. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.2157-2159.2001 · Cited by 168
Detection of Multidrug Resistance in Mycobacterium tuberculosis
Sekiguchi, J.-I., Miyoshi-Akiyama, T., Augustynowicz-Kopeć, E., Zwolska, Z., Kirikae, F., Toyota, E., Kobayashi, I., Morita, K., Kudo, K., Kato, S., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00750-06 · Cited by 166
Alland, D., Steyn, A. J., Weisbrod, T., Aldrich, K., & Jacobs, W. R. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.7.1802-1811.2000 · Cited by 165
Siddiqi, N., Shamim, M., Hussain, S., Choudhary, R. K., Ahmed, N., Prachee, Banerjee, S., Savithri, G. R., Alam, M., Pathak, N., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.443-450.2002 · Cited by 165
Rouse, D. A., Li, Z., Bai, G. H., & Morris, S. L. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2472 · Cited by 160
BERNSTEIN, J., Lott, W. A., Steinberg, B. A., & Yale, H. L. (1952) · PubMed · doi:10.1164/art.1952.65.4.357 · Cited by 160
Rouse, D. A., DeVito, J. A., Li, Z., Byer, H., & Morris, S. L. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.00133.x · Cited by 158
Miesel, L., Weisbrod, T. R., Marcinkeviciene, J. A., Bittman, R., & Jacobs, W. R. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.9.2459-2467.1998 · Cited by 155
Zhang, M., Yue, J., Yang, Y., Zhang, H., Lei, J.-Q., Jin, R., Zhang, X., & Wang, H. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.11.5477-5482.2005 · Cited by 155
The Prodrug Activator EtaA from Mycobacterium tuberculosis Is a Baeyer-Villiger Monooxygenase
Fraaije, M. W., Kamerbeek, N. M., Heidekamp, A. J., Fortin, R., & Janssen, D. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307770200 · Cited by 153
Sreevatsan, S., Pan, X., Zhang, Y., Deretic, V. P., & Musser, J. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.3.600 · Cited by 152
Pasca, M. R., Guglierame, P., Rossi, E. D., Zara, F., & Riccardi, G. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4775-4777.2005 · Cited by 144
Silva, P. E. A., Bigi, F., Santangelo, M. D. L. P., Romano, M. I., Martín, C., Cataldi, A. A., & Aínsa, J. A. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.3.800-804.2001 · Cited by 141
Mycobacterial FurA is a negative regulator of catalase-peroxidase gene katG
Zahrt, T. C., Song, J., Siple, J., & Deretic, V. P. (2001) · Molecular Microbiology · doi:10.1111/j.1365-2958.2001.02321.x · Cited by 140
Kiepiela, P., Bishop, K. S., Smith, A. N., Roux, L., & York, D. F. (2000) · Tubercle and Lung Disease · doi:10.1054/tuld.1999.0231 · Cited by 139
Pym, A. S., Domenech, P., Honoré, N., Song, J., Deretic, V., & Cole, S. T. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02427.x · Cited by 138
The Chemical Approach to the Control of Tuberculosis
FOX, H. H. (1952) · Science · doi:10.1126/science.116.3006.129 · Cited by 134
Basso, L. A., Zheng, R., Musser, J. M., Jacobs, W. R., & Blanchard, J. S. (1998) · The Journal of Infectious Diseases · doi:10.1086/515362 · Cited by 133
Heinz, U., Hegetschweiler, Κ., Acklin, P., Faller, B., Lattmann, R., & Schnebli, H. P. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990903)38:17<2588::aid-anie2588>3.0.co;2-8 · Cited by 131
Mycobacterium tuberculosis dihydrofolate reductase is a target for isoniazid
Argyrou, A., Vetting, M. W., Aladegbami, B. G., & Blanchard, J. S. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1089 · Cited by 131
Brossier, F., Véziris, N., Truffot-Pernot, C., Jarlier, V., & Sougakoff, W. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01054-06 · Cited by 131
Payton, M. A., Auty, R., Delgoda, R., Everett, M. J., & Sim, E. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.4.1343-1347.1999 · Cited by 131
Alland, D., Kramnik, I., Weisbrod, T. R., Otsubo, L., Cerny, R., Miller, L. P., Jacobs, W. R., & Bloom, B. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13227 · Cited by 130
Lee, A. S. G., Lim, I. H. K., Tang, L. L. H., Telenti, A., & Wong, S. Y. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.2087 · Cited by 127
Saint‐Joanis, B., Souchon, H., Wilming, M., Johnsson, K., Alzari, P. M., & Cole, S. T. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3380753 · Cited by 126
Effect of Mutation and Genetic Background on Drug Resistance in Mycobacterium tuberculosis
Fenner, L., Egger, M., Bodmer, T., Altpeter, E., Zwahlen, M., Jaton, K., Pfyffer, G. E., Borrell, S., Dubuis, O., Bruderer, T., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06460-11 · Cited by 124
Guo, H., Seet, Q., Denkin, S. M., Parsons, L. M., & Zhang, Y. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46718-0 · Cited by 115
Haas, W., Schilke, K., Brand, J., Amthor, B., Weyer, K., Fourie, P. B., Bretzel, G., Sticht-Groh, V., & Bremer, H. J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1601 · Cited by 115
Cockerill, F. R., Uhl, J. R., Temesgen, Z., Zhang, Y., Stockman, L., Roberts, G. D., Williams, D. L., & Kline, B. C. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.1.240 · Cited by 114
Silva, M. S. N., Senna, S. G., Ribeiro, M. O., Valim, A. R. D. M., Telles, M. A. S., Kritski, A. L., Morlock, G. P., Cooksey, R. C., Zaha, A., & Rossetti, M. L. R. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.9.4471-4474.2003 · Cited by 111
Lipin, M. Y., Stepanshina, V. N., Shemyakin, I. G., & Shinnick, T. M. (2007) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01711.x · Cited by 109
Wengenack, N. L., Uhl, J. R., Amand, A. L. S., Tomlinson, A. J., Benson, L. M., Naylor, S., Kline, B. C., Cockerill, F. R., & Rusnak, F. M. (1997) · The Journal of Infectious Diseases · doi:10.1086/514096 · Cited by 108
Caws, M., Phan, M., Tho, D. Q., Lan, N. T. N., Hoa, D. V., & Farrar, J. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00330-06 · Cited by 107
Chan, R. C. Y., Hui, M., Chan, E. W., Au, T. K., Chin, M. L., Yip, C. K., Au-Yeang, C., Yeung, C. Y. L., Kam, K. M., Yip, P. C. W., et al. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm054 · Cited by 107
Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico
Ramaswamy, S. V., Dou, S.-J., Rendón, A., Yang, Z., Cave, M. D., & Graviss, E. A. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.05343-0 · Cited by 103
Cardoso, R. F., Cooksey, R. C., Morlock, G. P., Barco, P., Cecon, L., Forestiero, F., Leite, C. Q. F., Sato, D. N., Shikama, M. D. L. M., Mamizuka, E. M., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3373-3381.2004 · Cited by 102
Middlebrook, G. (1952) · PubMed · Cited by 100
Brossier, F., Véziris, N., Truffot-Pernot, C., Jarlier, V., & Sougakoff, W. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01030-10 · Cited by 98
Bhakta, S., Besra, G. S., Upton, A. M., Parish, T., Sholto-Douglas-Vernon, C., Gibson, K. J. C., Knutton, S., Gordon, S., daSilva, R. P., Anderton, M. C., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031956 · Cited by 98
Cohn, M. L., Kovitz, C., ODA, U., & Middlebrook, G. (1954) · PubMed · doi:10.1164/art.1954.70.4.641 · Cited by 98
Yuan, X., Zhang, T., Kawakami, K., Zhu, J., Li, H., Lei, J., & Tu, S.-H. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06860-11 · Cited by 91
Ando, H., Kondo, Y., Suetake, T., Toyota, E., Kato, S., Mori, T., & Kirikae, T. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01691-09 · Cited by 91
Huang, W., Chen, H.-Y., Kuo, Y.-M., & Jou, R. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.02499-08 · Cited by 89
Wei, C., Lei, B., Musser, J. M., & Tu, S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.670-675.2003 · Cited by 89
Chemotherapy of Pulmonary Tuberculosis
Crofton, J. (1959) · BMJ · doi:10.1136/bmj.1.5138.1610 · Cited by 88
Nguyen, M., Quémard, A., Broussy, S., Bernadou, J., & Meunier, B. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2137-2144.2002 · Cited by 86
Upton, A. M., Mushtaq, A., Victor, T. C., Sampson, S. L., Sandy, J., Smith, D., van Helden, P. D., & Sim, E. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02648.x · Cited by 86
Chemotherapy of Experimental Tuberculosis.
Perlman, H., BROWN, H., & Raiziss, G. W. (1941) · American Review of Tuberculosis and Pulmonary Diseases · Cited by 86
Proteome-wide Profiling of Isoniazid Targets in Mycobacterium tuberculosis
Argyrou, A., Jin, L., Siconolfi-Baez, L., Angeletti, R. H., & Blanchard, J. S. (2006) · Biochemistry · doi:10.1021/bi061874m · Cited by 81
Kremer, L., Dover, L. G., Morbidoni, H. R., Vilchèze, C., Maughan, W. N., Baulard, A. R., Tu, S., Honoré, N., Deretic, V. P., Sacchettini, J. C., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302435200 · Cited by 81
Self-citationComparative analysis of mutants in the mycothiol biosynthesis pathway in Mycobacterium smegmatis
Rawat, M., Johnson, C., Cadiz, V., & Av‐Gay, Y. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.142 · Cited by 80
Jnawali, H. N., Hwang, S. C., Park, Y. K., Kim, H.-J., Lee, Y. S., Chung, G. T., Choe, K. H., & Ryoo, S. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.02.035 · Cited by 79
Wang, K., Pei, H., Huang, B., et al. (2012) · Current Microbiology · doi:10.1007/s00284-012-0215-3 · Cited by 78
Chapman, P. F. (1934) · BMJ · doi:10.1136/bmj.2.3857.1073-b · Cited by 78
Baker, L. V., Brown, T., Maxwell, O., Gibson, A. L., Fang, Z., Yates, M. D., & Drobniewski, F. A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.4.1455-1464.2005 · Cited by 78
Marttila, H., Soini, H., Huovinen, P., & Viljanen, M. K. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.9.2187 · Cited by 76
Effects of Ethionamide and Isoxyl on Mycolic Acid Synthesis in Mycobacterium tuberculosis bcg
Winder, F. G., Collins, P. B., & Whelan, D. (1971) · Journal of General Microbiology · doi:10.1099/00221287-66-3-379 · Cited by 75
Rv1218c, an ABC Transporter of Mycobacterium tuberculosis with Implications in Drug Discovery
Balganesh, M., Kuruppath, S., Marcel, N., Sharma, S., Nair, A. V., & Sharma, U. K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00610-10 · Cited by 73
Wang, F., Jain, P., Gülten, G., Liu, Z., Feng, Y., Ganesula, K., Motiwala, A. S., Ioerger, T. R., Alland, D., Vilchèze, C., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00453-10 · Cited by 72
Self-citationLavender, C. J., Globan, M., Sievers, A. S., Billman‐Jacobe, H., & Fyfe, J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.4068-4074.2005 · Cited by 70
Isoniazid-Resistance and Catalase Activity of Tubercle Bacilli1
Middlebrook, G. (2019) · American Review of Tuberculosis · Cited by 70
inhA promoter mutations: a gateway to extensively drug-resistant tuberculosis in South Africa?
Müller, B., Streicher, E. M., Hoek, K. G. P., Tait, M., Trollip, A. P., Bosman, M. E., Coetzee, G. J., Chabula-Nxiweni, E. M., Hoosain, E., van Pittius, N. C. G., et al. (2011) · PubMed · Cited by 69
Ducasse-Cabanot, S., Cohen‐Gonsaud, M., Marrakchi, H., Nguyen, M., Zerbib, D., Bernadou, J., Daffé, M., Labesse, G., & Quémard, A. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.242-249.2004 · Cited by 66
Dias, M. V. B., Vasconcelos, I. B., Prado, A. M. X., Fadel, V., Basso, L. A., de Azevedo, W. F., & Santos, D. S. (2007) · Journal of Structural Biology · doi:10.1016/j.jsb.2007.04.009 · Cited by 65
Pretorius, G. S., van Helden, P. D., Sirgel, F. A., Eisenach, K. D., & Victor, T. C. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.10.2276 · Cited by 60
Davidson, L. A., & Takayama, K. (1979) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.16.1.104 · Cited by 60
Luò, T., Zhao, M., Li, X., Xu, P., Gui, X., Pickerill, S., DeRiemer, K., Mei, J., & Gao, Q. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00964-09 · Cited by 58
Clinical Evaluation of Isoniazid
Middlebrook, G., & DRESSLER, S. H. (1954) · American Review of Tuberculosis · doi:10.1164/art.1954.70.6.1102 · Cited by 57
van Doorn, H. R., Kuijper, E. J., ENDE, A. V. D., Welten, A. G. A., van Soolingen, D., de Haas, P. E. W., & Dankert, J. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.4.1591-1594.2001 · Cited by 56
Abe, C., Kobayashi, I., Mitarai, S., Wada, M., Kawabe, Y., Takashima, T., Suzuki, K., Sng, L., Wang, S., Htay, H., et al. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00561-08 · Cited by 56
Boonaiam, S., Chaiprasert, A., Prammananan, T., & Leechawengwongs, M. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02838.x · Cited by 55
Ando, H., Kitao, T., Miyoshi‐Akiyama, T., Kato, S., Mori, T., & Kirikae, T. (2011) · Molecular Microbiology · doi:10.1111/j.1365-2958.2011.07547.x · Cited by 55
Xu, X., Vilchèze, C., Av‐Gay, Y., Gómez-Velasco, A., & Jacobs, W. R. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00020-11 · Cited by 55
Self-citationIsoniazid resistance without a loss of fitness in Mycobacterium tuberculosis
Lee, J., Ammerman, N. C., Nolan, S. T., Geiman, D. E., Lun, S., Guo, H., & Bishai, W. R. (2012) · Nature Communications · doi:10.1038/ncomms1724 · Cited by 53
Susceptibilities of oxyR regulon mutants of Escherichia coli and Salmonella typhimurium to isoniazid
Rosner, J. L. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.10.2251 · Cited by 51
Lee, H., Cho, S.-N., Bang, H. E., Lee, J. H., Bai, G. H., Kim, S. J., & Kim, J. D. (2000) · PubMed · Cited by 46
Fang, Z., Doig, C., Rayner, A. W., Kenna, D., Watt, B., & Forbes, K. J. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.4.998-1003.1999 · Cited by 45
Cardoso, R. F., Cardoso, M. A., Leite, C. Q. F., Sato, D. N., Mamizuka, E. M., Hirata, R. D. C., de Mello, F. A. F., & Hirata, M. H. (2007) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762007000100009 · Cited by 42
Leung, K.-H., Yip, C. W., Yeung, Y. L., Wong, K. L., Chan, W. Y., Chan, M. Y., & Kam, K. M. (2010) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2010.04840.x · Cited by 37
Wang, X., Gu, J., Wang, T., Bi, L., Zhang, Z., Cui, Z., Wei, H., Deng, J., & Zhang, X. (2011) · Molecular Microbiology · doi:10.1111/j.1365-2958.2011.07892.x · Cited by 37
Ristow, M., Möhlig, M., Rifai, M., Schatz, H., Feldmann, K., & Pfeiffer, A. F. H. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91351-3 · Cited by 36
Catalase and Peroxidase in Mycobacteria
WINDER, F. G. (1960) · American Review of Respiratory Disease · doi:10.1164/arrd.1960.81.1p1.68 · Cited by 35
Vilchèze, C., Av‐Gay, Y., Barnes, S. W., Larsen, M. H., Walker, J. R., Glynne, R. J., & Jacobs, W. R. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00564-11 · Cited by 34
Self-citationHo, Y. M., Sun, Y.-J., Wong, S. Y., & Lee, A. S. G. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00433-09 · Cited by 29
Mo, L., Zhang, W., Wang, J., Weng, X. H., Chen, S., Shao, L., Pang, M.-Y., & Chen, Z. W. (2004) · Microbial Drug Resistance · doi:10.1089/mdr.2004.10.269 · Cited by 28
Chen, P., & Bishai, W. R. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5099-5106.1998 · Cited by 28
Mutational and expression analysis of tbnat and its response to isoniazid
Sholto-Douglas-Vernon, C., Sandy, J., Victor, T. C., Sim, E., & van Helden, P. D. (2005) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46153-0 · Cited by 24
Projahn, M., Köser, C. U., Homolka, S., Summers, D., Archer, J. A. C., & Niemann, S. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00555-11 · Cited by 20
The ethionamide sensitivity of british pre-treatment strains of mycobacterium tuberculosis
Lefford, M. J. (1966) · Tubercle · doi:10.1016/s0041-3879(66)80036-3 · Cited by 16
Davis, W. B., & Weber, M. M. (1977) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.12.2.213 · Cited by 16
Soudani, A., Fredj, S. H., Zribi, M., Messaadi, F., Messaoud, T., Masmoudi, A., Zribi, M., & Fendri, C. (2011) · The Journal of Microbiology · doi:10.1007/s12275-011-0268-1 · Cited by 12
Escalante, P., McKean‐Cowdin, R., Ramaswamy, S. V., Williams‐Bouyer, N., Teeter, L. D., Jones, B. E., & Graviss, E. A. (2013) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.12.0380 · Cited by 6
Mutations of katG and inhA in MDR M. tuberculosis
Lin, H. H., Kim, H.-Y., Yun, Y.-J., Park, C. G., Kim, B., Park, Y.-G., & Kook, Y. (2007) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2007.63.2.128 · Cited by 6
Cited by
Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives
Gygli, S. M., Borrell, S., Trauner, A., & Gagneux, S. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux011 · Cited by 457
Metabolic principles of persistence and pathogenicity in Mycobacterium tuberculosis
Ehrt, S., Schnappinger, D., & Rhee, K. Y. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0013-4 · Cited by 296
Metadata
- Authors
- Vilchèze, C., & Jacobs JR., W. R.
- Venue
- Microbiology Spectrum
- Publisher
- American Society for Microbiology
- Published
- 2014-08-15
- Volume
- 2
- Issue
- 4
- Pages
- MGM2-0014
- ISSN
- 2165-0497 (ISSN-L)
- OpenAlex
- W2028522909
- Cited by
- 289
- References
- 146
- FWCI
- 8.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.